5th TDM of Biologics Symposium

The 5th TDM of Biologics Symposium, organized by Sanquin, Reade and the Amsterdam UMC, brings together experts focused on therapeutic drug monitoring (TDM) of biologics. This field continues to shape precision medicine and patient-specific treatment strategies. apDia will attend the 5th TDM of Biologics Symposium to stay aligned with current developments and clinical needs.

The symposium is endorsed by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). This recognition highlights the scientific relevance of the program and its value for professionals working in TDM and clinical diagnostics.

TDM of biologics plays a key role in optimizing dosing and improving treatment outcomes. Accurate measurement of drug levels and anti-drug antibodies supports clinicians in making informed decisions. Events like the 5th TDM of Biologics Symposium highlight how laboratory diagnostics contribute to this process.

apDia supports laboratories with reliable ELISA solutions designed for therapeutic drug monitoring. Our assays enable consistent and reproducible measurement of biologics and related biomarkers. This aligns with the growing demand for robust IVD tools in clinical practice. Learn more about our solutions here: apdia brochures.

The symposium also offers a platform for exchanging insights between clinicians, researchers, and diagnostic specialists. It reflects the ongoing shift toward personalized medicine and data-driven healthcare decisions.

📅  Date: December 11, 2026
📍  Location: Public library of Amsterdam (OBA), Netherlands
🔗  For more information, visit https://www.tdm-of-biologics.nl/